|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Tango Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
EyePoint Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
PolyPid Ltd. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Orange Grove Bio LLC |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
SpringWorks Therapeutics Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Trinity Biotech Plc |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Trinity Biotech Plc |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Biogen Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Protara Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
23andMe, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Neurimmune AG |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
ZyVersa Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
MBX Biosciences, Inc. |
MBX Capital, LLC |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Triastek, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
RAPT Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Cabaletta Bio, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 31 Jan 2024
|
Related companies:
Eargo, Inc |
|